Edrophonium Injection

25 August 2009

Products Affected - Description

Edrophonium chloride (Enlon), Baxter
10 mg/mL, 15 mL multiple-dose vial (NDC 10019-0873-15) - discontinued

Edrophonium chloride (10 mg/mL)/Atropine sulfate (0.14 mg/mL) (Enlon Plus), Baxter
5 mL ampul (NDC 10019-0180-05) - discontinued
15 mL multiple-dose vial (NDC 10019-0195-15) - discontinued

Reason for the Shortage

• Baxter would not state a reason for the discontinuation.
• Bioniche Pharma recently acquired rights to Enlon and Enlon Plus.
• There are no other suppliers of edrophonium injection or edrophonium/atropine injection.

Estimated Resupply Dates

• Baxter discontinued Enlon and Enlon Plus.
• Bioniche Pharma has available Enlon 15 mL vials (NDC 67457-0190-15), Enlon Plus 5 mL ampuls (NDC 67457-0192-05), and Enlon Plus 15 mL multiple-dose vials (NDC 67457-0191-15).

Related Shortages

• Diatrizoate Meglumine Injection— Resolved
• Diatrizoate Sodium Injection— No Longer Available
• Indocyanine Green— Resolved
• Technetium Tc99m Generators

Updated

August 25, 2009; July 22, 2009; June 22, 2009; June 1, 2009; May 20, 2009; April 20, 2009; March 27, 2009; March 3, 2009; February 10, 2009; January 21, 2009; January 8, 2009; December 29, 2008; December 8, 2008; November 25, 2008; November 5, 2008; October 20, 2008; September 19, 2008; February 25, 2008; February 21, 2008; December 18, 2007. Copyright 2009, University of Utah, Drug Information Service.

Back to Drug Shortage Product Bulletins